These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 18685377

  • 1. Is there a common mechanism linking muscle wasting in various disease types?
    Tisdale MJ.
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):287-92. PubMed ID: 18685377
    [Abstract] [Full Text] [Related]

  • 2. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ.
    J Support Oncol; 2005 Dec; 3(3):209-17. PubMed ID: 15915823
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1,2,6-triphosphate.
    Russell ST, Siren PM, Siren MJ, Tisdale MJ.
    Exp Cell Res; 2010 Jan 15; 316(2):286-95. PubMed ID: 19716818
    [Abstract] [Full Text] [Related]

  • 4. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
    Wyke SM, Tisdale MJ.
    Life Sci; 2006 May 15; 78(25):2898-910. PubMed ID: 16343552
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of skeletal muscle atrophy.
    Ventadour S, Attaix D.
    Curr Opin Rheumatol; 2006 Nov 15; 18(6):631-5. PubMed ID: 17053511
    [Abstract] [Full Text] [Related]

  • 6. Novel aspects on the regulation of muscle wasting in sepsis.
    Hasselgren PO, Menconi MJ, Fareed MU, Yang H, Wei W, Evenson A.
    Int J Biochem Cell Biol; 2005 Oct 15; 37(10):2156-68. PubMed ID: 16125115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of glucocorticoids in the molecular regulation of muscle wasting.
    Menconi M, Fareed M, O'Neal P, Poylin V, Wei W, Hasselgren PO.
    Crit Care Med; 2007 Sep 15; 35(9 Suppl):S602-8. PubMed ID: 17713416
    [Abstract] [Full Text] [Related]

  • 9. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
    Du J, Hu Z, Mitch WE.
    Int J Biochem Cell Biol; 2005 Oct 15; 37(10):2147-55. PubMed ID: 15982920
    [Abstract] [Full Text] [Related]

  • 10. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM.
    Lung Cancer; 2012 Apr 15; 76(1):112-7. PubMed ID: 22018880
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid-induced skeletal muscle atrophy.
    Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP.
    Int J Biochem Cell Biol; 2013 Oct 15; 45(10):2163-72. PubMed ID: 23806868
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I).
    Russell ST, Eley H, Tisdale MJ.
    Cell Signal; 2007 Jul 15; 19(7):1583-95. PubMed ID: 17376652
    [Abstract] [Full Text] [Related]

  • 13. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
    Russell ST, Eley H, Tisdale MJ.
    Cell Signal; 2007 Aug 15; 19(8):1797-806. PubMed ID: 17532611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions.
    Arthur PG, Grounds MD, Shavlakadze T.
    Curr Opin Clin Nutr Metab Care; 2008 Jul 15; 11(4):408-16. PubMed ID: 18542000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.
    Constantin D, Constantin-Teodosiu D, Layfield R, Tsintzas K, Bennett AJ, Greenhaff PL.
    J Physiol; 2007 Aug 15; 583(Pt 1):381-90. PubMed ID: 17540700
    [Abstract] [Full Text] [Related]

  • 19. Molecular signaling pathways regulating muscle proteolysis during atrophy.
    Franch HA, Price SR.
    Curr Opin Clin Nutr Metab Care; 2005 May 15; 8(3):271-5. PubMed ID: 15809529
    [Abstract] [Full Text] [Related]

  • 20. Recent progress in elucidating signalling proteolytic pathways in muscle wasting: potential clinical implications.
    Polge C, Heng AE, Combaret L, Béchet D, Taillandier D, Attaix D.
    Nutr Metab Cardiovasc Dis; 2013 Dec 15; 23 Suppl 1():S1-5. PubMed ID: 23149071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.